Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Monahan

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
Gene therapy in an era of emerging treatment options for hemophilia BP E Monahan
Gene Therapy|February 19, 2000
AAV vectors: is clinical success on the horizon?P E Monahan, R J Samulski
Molecular Medicine Today|November 14, 2000
Adeno-associated virus vectors for gene therapy: more pros than cons?P E Monahan, R J Samulski
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 15, 2009
Familial deficiency of vitamin K-dependent clotting factorsB W Weston, P E Monahan
Current Gene Therapy|December 20, 2003
Evaluation of risks related to the use of adeno-associated virus-based vectorsL Tenenbaum, E Lehtonen, P E Monahan
Gene Therapy|August 18, 2001
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisD M McCarty, P E Monahan, R J Samulski
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, ArgentinaR R Montgomery, P E Monahan, M C Ozelo
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2013
Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection databaseJ Puetz, J M Soucie, C L Kempton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectorsH Chao, P E Monahan, Y Liu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwideK E Van Cott, P E Monahan, T C Nichols, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
Gene therapy in an era of emerging treatment options for hemophilia BP E Monahan
Gene Therapy|February 19, 2000
AAV vectors: is clinical success on the horizon?P E Monahan, R J Samulski
Molecular Medicine Today|November 14, 2000
Adeno-associated virus vectors for gene therapy: more pros than cons?P E Monahan, R J Samulski
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 15, 2009
Familial deficiency of vitamin K-dependent clotting factorsB W Weston, P E Monahan
Current Gene Therapy|December 20, 2003
Evaluation of risks related to the use of adeno-associated virus-based vectorsL Tenenbaum, E Lehtonen, P E Monahan
Gene Therapy|August 18, 2001
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisD M McCarty, P E Monahan, R J Samulski
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, ArgentinaR R Montgomery, P E Monahan, M C Ozelo
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2013
Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection databaseJ Puetz, J M Soucie, C L Kempton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectorsH Chao, P E Monahan, Y Liu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwideK E Van Cott, P E Monahan, T C Nichols, et al.
Pageof 3